Solventum Q2 FY2026: organic sales +9.5%, adjusted EPS $2.55, guidance up
Solventum beat on adjusted profit and raised full-year guidance on organic sales, adjusted EPS and free cash flow, so the quarter reads Bullish — but much of the strength came from items that will not repeat. Read the top line two ways: reported sales rose 2.2% while organic sales rose 9.5%, because the Purification and Filtration business sold in September 2025 still sat in last year's reported numbers.
1 · Expected vs. Actual
Free preview belowGAAP diluted EPS was $0.53 while adjusted diluted EPS was $2.55, up 50.9% and above the $1.9443 consensus estimate. The $2.02 gap is mostly amortization of acquisition-related intangibles, 3M separation costs and certain litigation costs. Adjusted gross margin reached 60.1% and adjusted operating margin 28.4%, helped by an IEEPA tariff refund and an ERP-timing benefit rather than by pricing or cost cuts alone.
Reported sales rose 2.2% to $2.209 billion, but organic sales rose 9.5% — the gap is mostly the divested Purification and Filtration business and a 1.0% currency tailwind. Management credits volume, product mix and advance orders placed ahead of ERP cutovers, so part of that 9.5% looks borrowed from later quarters rather than earned in this one.
Log in to read 5 analyses a week for free
Create a free account to read 5 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-09-17
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.